Cathay AfricInvest Innovation

Cathay AfricInvest Innovation is a joint venture fund between Cathay Innovation, the global venture firm with offices in Paris, San Francisco, and Shanghai, and AfricInvest, the leading pan-African private investor. The fund’s mandate is to back African technology companies at Series A and Series B stages, with sector breadth across fintech, commerce, logistics, healthcare, and emerging tech. Healthcare exposure is real but selective, with the fund’s lens favoring companies that can scale across multiple African markets and benefit from both Cathay’s global network and AfricInvest’s deep continental relationships. Check sizes are plausibly $2M to $10M, with capacity to lead or co-lead and to follow on through Series B. For healthcare AI founders, this fund is the right partner if you are an African or Africa-focused healthcare AI company at Series A or later — telemedicine platforms, pharmacy supply chain, diagnostics distribution, employer benefits — with proven traction in at least one African market and ambition to expand pan-continentally. Founders who should approach: African-headquartered or Africa-deploying healthcare AI startups with revenue, a credible local team, and a multi-market expansion plan. Founders who should not approach: pre-revenue teams, US- or Europe-only digital health, biotech, and any company without a credible African operating story. The fund’s value-add is the dual-network effect, downstream institutional capital from both Cathay and AfricInvest, and global commercial relationships. Entry path is warm introduction through African operators, Cathay’s portfolio companies, or AfricInvest’s pan-African network. Cold outbound through Cathay’s website is feasible but lower-yield.